16 results on '"Naito, Sei"'
Search Results
2. PD55-10 IMPACT OF GERMLINE HLA STATUS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB
3. Risk of SOFA Deterioration in Conservative Treatment for Emphysematous Pyelonephritis: Pitfalls of Current Trends in Therapeutics from Multicenter Clinical Experience
4. MP16-01 ROLE OF FGFR4 IN CLEAR CELL RENAL CARCINOMA AND ITS POTENTIAL AS A NEW THERAPEUTIC TARGET
5. MP16-10 EIF4E PHOSPHORYLATION INHIBITS METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA
6. PD12-06 EXTERNAL VALIDATION OF CHOKAI SCORE AND COMPARISON WITH STONE SCORE FOR THE PREDICTION OF URETERAL STONES IN JAPAN: A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY
7. MP88-18 ERK5 IS A PROMISING THERAPEUTIC TARGET FOR CLEAR CELL RENAL CELL CARCINOMA
8. MP92-06 LDL CHOLESTEROL COMPROMISES EFFICACY OF MULTITARGETED TYROSINE KINASE INHIBITORS AGAINST RENAL CELL CARCINOMA
9. 2007 ESTIMATED GFR AS A BIOMARKER OF EFFICACY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH SUNITINIB
10. 1800 PROGNOSTIC FACTORS OF METASTATIC RENAL CELL CARCINOMA PATIENTS WITH REMOVED METASTASES: A MULTICENTER STUDY OF 559 PATIENTS
11. 523 GLYCOGEN SYNTHASE KINASE INHIBITOR AND CISPLATIN SYNERGICALLY INHIBIT GROWTH OF BLADDER CANCER IN XENOGRAFT RODENT MODEL
12. 117 LOW MIR-199A EXPRESSION IN RENAL CELL CARCINOMA (RCC) IS RELATED TO MALIGNANT PHENOTYPE VIA UPREGULATION OF GSK-3BETA
13. 1151 DIRECT ANTITUMOR EFFECT OF BACILLUS CALMETTE-GUERIN IN HIGH GRADE UROTHELIAL CANCER CELLS WHICH EXPRESS VLA5 (ALPHA 5 BETA 1 INTEGRIN)
14. ROLE OF THE NUCLEAR ACCUMULATION OF GSK-3BETA IN BLADDER CANCER MALIGNANT PHENOTYPE - POTENTIAL THERAPEUTIC TARGET
15. INHIBITION OF GSK-3ß ACTIVITY SUPPRESSES THE PROLIFERATION AND INDUCES APOPTOSIS IN BLADDER CANCER
16. SMAC-N7 PEPTIDE WAS MORE POTENT THAN XIAP GENE TARGETING IN SENSITIZING RENAL CANCER CELLS TO APOPTOTIC STIMULI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.